Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
US large, mid, and small-cap retirement index funds provide layered exposure to varying market segments. This intro covers allocation ideas and risk considerations.
26,127 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Dell Technologies could be positioning itself as a key AI infrastructure player. This article dives into the AI drive...
When a stock slips, smart investors look past the temporary dip. Domino's remains a dominant player with growing digi...
A high-level insider move follows a strong stock run. This article breaks down what the CFO’s sale signals, how to re...
A shocking on-stage moment can ripple through a performer's finances. This article breaks down how reportedly used fa...
A new financing tool is speeding up reimbursements for Municipal Utility Districts in Texas, promising higher returns...
A major bet from a savvy institutional investor puts Brookdale Senior Living in the spotlight. Mason Capital Manageme...
Internal investigators allege Binance processed more than $1 billion in transfers to Iran-linked entities, centering ...
AI-driven analysis explores XRP's possible path to higher prices if Ripple secures a Fed master account. The piece ou...
Digital Asset Holdings closed a $355 million funding round led by A16Z, highlighting growing investor interest in tok...
A SpaceX AI push could rewrite how we think about tech bets. If spacex just spent billion, investors should watch how...
SpaceX is redefining its business beyond rocket launches. This article explains the spacex made huge pivot, what it c...